Pyoderma gangrenosum in myclodysplasia responding to granulocyte macrophage-colony stimulating factor (GM-CSF)
- 1 April 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 136 (4) , 637-638
- https://doi.org/10.1111/j.1365-2133.1997.tb02169.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Efficacy of human intravenous immune globulin in pyoderma gangrenosumJournal of the American Academy of Dermatology, 1995
- PYODERMA GANGRENOSUM IN A PATIENT WITH RHEUMATOID ARTHRITIS RESPONDING TO TREATMENT WITH CYCLOSPORIN ARheumatology, 1994
- Leukocyte Colony-Stimulating FactorsArchives of Dermatology, 1994
- Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitidesArchives of Dermatology, 1994
- Pyoderma gangrenosumClinics in Dermatology, 1993
- Pyoderma gangrenosum, polycythemia rubra vera, and the development of leukemiaJournal of the American Academy of Dermatology, 1992
- In vivo administration of granulocyte‐macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromesBritish Journal of Haematology, 1991
- Treatment of pyoderma gangrenosum with cyclosporine: Results in seven patientsJournal of the American Academy of Dermatology, 1991
- Pyoderma gangrenosum in myelodysplasia and acute leukaemiaPostgraduate Medical Journal, 1985
- Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosisBritish Journal of Dermatology, 1982